A detailed history of Hrt Financial LP transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 84,762 shares of SENS stock, worth $38,990. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84,762
Previous 160,329 47.13%
Holding current value
$38,990
Previous $64,000 54.69%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$0.32 - $0.49 $24,181 - $37,027
-75,567 Reduced 47.13%
84,762 $29,000
Q2 2024

Aug 12, 2024

BUY
$0.37 - $0.52 $59,321 - $83,371
160,329 New
160,329 $64,000
Q3 2022

Nov 14, 2022

BUY
$1.02 - $2.23 $48,470 - $105,969
47,520 New
47,520 $62,000
Q2 2022

Aug 12, 2022

SELL
$0.94 - $1.94 $195,249 - $402,961
-207,712 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.54 - $3.71 $303,409 - $730,940
197,019 Added 1842.5%
207,712 $409,000
Q4 2021

Feb 14, 2022

BUY
$2.58 - $3.91 $27,587 - $41,809
10,693 New
10,693 $28,000
Q2 2021

Aug 16, 2021

SELL
$1.71 - $4.14 $1.34 Million - $3.25 Million
-785,781 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$0.85 - $5.27 $667,913 - $4.14 Million
785,781 New
785,781 $2.07 Million
Q4 2020

Feb 16, 2021

SELL
$0.36 - $0.95 $6,732 - $17,765
-18,700 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$0.36 - $0.53 $122,105 - $179,766
-339,182 Reduced 94.77%
18,700 $7,000
Q2 2020

Aug 14, 2020

BUY
$0.39 - $0.69 $139,573 - $246,938
357,882 New
357,882 $139,000
Q1 2020

May 15, 2020

SELL
$0.56 - $1.62 $36,446 - $105,434
-65,083 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$0.83 - $1.3 $172,503 - $270,185
-207,835 Reduced 76.15%
65,083 $59,000
Q3 2019

Nov 14, 2019

BUY
$0.97 - $1.94 $264,730 - $529,460
272,918 New
272,918 $269,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $214M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.